|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,72,600.00 KRW | -1.82% |
|
-1.43% | +0.13% |
| 14/07 | Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar | MT |
| 07/07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELLTRION, INC. | Other Biotechnology & Medical Research | -1.82% | -1.43% | +0.13% | +0.52% | -23.10% | 2.68TCr |  |  |  |
- Stock Market
- Stocks
- A068270 Stock
- Charts Celltrion, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition